Last update 20 Oct 2025

AVANZ Phleum pratense

Overview

Basic Info

Drug Type
Allergen extract
Synonyms-
Target-
Action
modulators
Mechanism
Immunomodulators
Therapeutic Areas
Immune System DiseasesInfectious DiseasesOtorhinolaryngologic Diseases+ [1]
Active Indication-
Inactive Indication
Rhinitis, AllergicRhinitis, Allergic, Seasonal
Originator Organization
ALK-Abello A/SALK-Abello A/S
Active Organization-
Inactive Organization
ALK-Abello A/SALK-Abello A/S
License Organization-
Drug Highest PhasePendingPhase 2/3
First Approval Date-
Regulation-
Login to view timeline

Related

4
Clinical Trials associated with AVANZ Phleum pratense
NCT02166268
/ CompletedPhase 2
Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber
NCT01438827
/ CompletedPhase 2/3
Avanz Phleum Pratense Maintenance Dose
NCT01454531
/ CompletedPhase 2/3
An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy
100 Clinical Results associated with AVANZ Phleum pratense
Login to view more data
100 Translational Medicine associated with AVANZ Phleum pratense
Login to view more data
100 Patents (Medical) associated with AVANZ Phleum pratense
Login to view more data
100 Deals associated with AVANZ Phleum pratense
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Rhinitis, AllergicPhase 3
Spain
ALK-Abello A/SALK-Abello A/S
01 Jun 2011
Rhinitis, Allergic, SeasonalPhase 2
Germany
ALK-Abello A/SALK-Abello A/S
01 Jun 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT01454531 (CTgov)
Phase 2/3
Rhinitis, Allergic
199
xzimsizjea = lkzpnvuebr rneiiaofig (nrszkyvfar, utdxxrdlaw - qtuqhjrfpe)
View more
-
06 Mar 2015
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free